Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Wu

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
JAMA|February 20, 2002
Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infantAbigail Freedman, Olubunmi Afonja, Mary Wu Chang, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymeraseAgustina P Bertolin, Florian Weissmann, Jingkun Zeng, et al.
Scientific Reports|February 24, 2024
Optimizing warfarin dosing for patients with atrial fibrillation using machine learningJeremy Petch, Walter Nelson, Mary Wu, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonucleaseBerta Canal, Ryo Fujisawa, Allison W McClure, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicaseJingkun Zeng, Florian Weissmann, Agustina P Bertolin, et al.
Journal of Virology|May 8, 2021
Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 GenomeValeria Lulla, Michal P Wandel, Katarzyna J Bandyra, et al.
Nature Communications|April 20, 2022
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancerJessica K Nelson, May Zaw Thin, Theodore Evan, et al.
Lancet (London, England)|January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patientsEdward J Carr, Mary Wu, Ruth Harvey, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like proteaseChew Theng Lim, Kang Wei Tan, Mary Wu, et al.
Science Translational Medicine|July 27, 2022
SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodiesKevin W Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
JAMA|February 20, 2002
Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infantAbigail Freedman, Olubunmi Afonja, Mary Wu Chang, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymeraseAgustina P Bertolin, Florian Weissmann, Jingkun Zeng, et al.
Scientific Reports|February 24, 2024
Optimizing warfarin dosing for patients with atrial fibrillation using machine learningJeremy Petch, Walter Nelson, Mary Wu, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonucleaseBerta Canal, Ryo Fujisawa, Allison W McClure, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicaseJingkun Zeng, Florian Weissmann, Agustina P Bertolin, et al.
Journal of Virology|May 8, 2021
Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 GenomeValeria Lulla, Michal P Wandel, Katarzyna J Bandyra, et al.
Nature Communications|April 20, 2022
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancerJessica K Nelson, May Zaw Thin, Theodore Evan, et al.
Lancet (London, England)|January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patientsEdward J Carr, Mary Wu, Ruth Harvey, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like proteaseChew Theng Lim, Kang Wei Tan, Mary Wu, et al.
Science Translational Medicine|July 27, 2022
SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodiesKevin W Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Pageof 8